Its announcement arrives to the heels of a similar licensing arrangement supplied in February to Adastra Labs, which experienced until now focused on crafting cannabis extracts. Adastra's license also makes it possible for it to produce and market psilocybin and psilocin – hallucinogens far more usually generally known as magic mushrooms that del